Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00259909 · ClinicalTrials.gov registry record
Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 259
- Enrollment target
NCT00259909: Completed study, sponsored by GlaxoSmithKline.
NCT00259909 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 259 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00259909 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 259 participants
- Enrollment target
Study Summary
The aim of the study is to develop a new patient-reported outcome (PRO) questionnaire measuring the impact of an acute exacerbation on daily lives of patients with chronic obstructive pulmonary disease (COPD). This questionnaire will aim to detect an acute exacerbation and resolution of exacerbation from the patient's perspective. At a later stage of development, this questionnaire will be able to measure the effect of anti bacterials in the treatment of acute exacerbations of COPD (AECOPD). This study will evaluate the factor structure, validity, reliability, and responsiveness of the GSK questionnaire in subjects who experience acute exacerbations of their COPD.
Primary Outcome
The SGRQ is a 50-item questionnaire with 76 weighted responses. It provides a Total score and three component scores: Symptoms (distress caused by respiratory symptoms), Activity (physical activities that cause or are limited by breathlessness), and Impacts (social and psychological effects of the disease). The Total score and each of the SGRQ sub-scores are scored from 0 to 100 where 0 indicates best and 100 indicates worst health. An increase in score indicates worsening health. A change in th
Interventions
- OTHER St. George's Respiratory Questionnaire
- OTHER GSK questionnaire
- OTHER Acute Short Form 12 version 2
- OTHER Global Efficacy questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2005-11-02 |
| Est. Completion | 2006-11-07 |
What the finished NCT00259909 record still lists
NCT00259909 is an observational study that tracks outcomes without assigning an intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which St. George's Respiratory Questionnaire is the first listed.
NCT00259909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00259909 about?
NCT00259909 is a clinical study titled "Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)". The aim of the study is to develop a new patient-reported outcome (PRO) questionnaire measuring the impact of an acute exacerbation on daily lives of patients with chronic obstructive pulmonary disease (COPD). This questionnaire will aim to detect an acute exacerbation and resolution of exacerbation...
What is the current status of trial NCT00259909?
This trial is currently completed. The enrollment target is 259 participants. The study started on 2005-11-02. Estimated completion is 2006-11-07.
What interventions are being tested in trial NCT00259909?
The interventions under investigation include: St. George's Respiratory Questionnaire (OTHER), GSK questionnaire (OTHER), Acute Short Form 12 version 2 (OTHER), Global Efficacy questionnaire (OTHER).
Who is sponsoring clinical trial NCT00259909?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02361320 · 259 participants · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- NCT06797258 · 259 participants · NA
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
- NCT06990425 · 259 participants · NA
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
- NCT07399977 · 259 participants · NA
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI